等待开盘 11-19 09:30:00 美东时间
+0.011
+2.75%
11月17日,Oncolytics Biotech(ONCY)收跌8.14%,报0.34美元,成交额47.06万美元,市值4456.82万美元。 行情数据 •...
11-17 08:26
Oncolytics Biotech and Coherus Oncology have entered a clinical supply agreement to evaluate the combination of pelareorep and toripalimab in patients with squamous cell anal carcinoma (SCAC). The study aims to assess whether pelareorep's immune activation mechanisms can enhance the antitumor activity of toripalimab in patients who have progressed on first-line treatment. Pelareorep stimulates antitumor immune responses, while toripalimab blocks ...
11-13 17:10
11月10日,Oncolytics Biotech(ONCY)收跌7.21%,报0.41美元,成交额47.32万美元,市值5345.75万美元。 行情数据 •...
11-10 08:24
The latest update is out from Oncolytics Biotech ( ($ONCY) ). On November 4, 20...
11-04 22:57
Oncolytics Biotech announced new data showing pelareorep, an investigational immunotherapy, significantly increased HPV-16-specific T cells and tumor-infiltrating lymphocytes (TILs) in second-line or later squamous cell anal cancer patients. When combined with a checkpoint inhibitor, pelareorep more than doubled the objective response rate and increased median duration of response by 50% compared to current therapies. The study also demonstrated ...
11-04 14:30
11月3日,Oncolytics Biotech(ONCY)收跌5.97%,报0.4美元,成交额34.46万美元,市值5244.83万美元。 行情数据 • 开盘...
11-03 08:20
Oncolytics Biotech® Inc. (NASDAQ:ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today announced updated data from Cohort 4 of its Phase 1/2 GOBLET study evaluating pelareorep in combination with atezolizumab (Tecentriq®) in patients with second-l...
10-27 21:32
Oncolytics Biotech Inc. reported updated data from Cohort 4 of its Phase 1/2 GOBLET study, showing pelareorep combined with atezolizumab achieved a median duration of response of approximately 15 months in second-line squamous cell anal cancer patients, exceeding historical results of 9.5 months for approved monotherapy. All responding patients survived over one year, with some exceeding 24 months. The FDA's Fast Track Designation and regulatory ...
10-27 13:30
10月27日,Oncolytics Biotech(ONCY)收跌5.79%,报0.47美元,成交额34.44万美元,市值6204.61万美元。 行情数据 •...
10-27 07:17
10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势,更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:20